Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study
Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival. Hypericum japonicum Thunb. (Tianjihuang), a traditional Chinese medicine exhibits promising anticancer properties. This study aim...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02633-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850224242863374336 |
|---|---|
| author | Bixing Liang Wenyu Wu Fan He Bing Yang Dongxin Tang |
| author_facet | Bixing Liang Wenyu Wu Fan He Bing Yang Dongxin Tang |
| author_sort | Bixing Liang |
| collection | DOAJ |
| description | Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival. Hypericum japonicum Thunb. (Tianjihuang), a traditional Chinese medicine exhibits promising anticancer properties. This study aims to elucidate the multi-target mechanisms of Tianjihuang in treating HCC using network pharmacology and molecular docking techniques. Methods The active components of Tianjihuang and their targets were retrieved from TCMSP, PubChem, and Swiss Target Prediction databases. HCC-related targets were identified using GeneCard, OMIM, and TTD databases, and overlapping targets were analyzed. Protein–protein interaction (PPI) networks were constructed and analyzed using Cytoscape. Functional enrichment analysis of key targets was performed via GO and KEGG pathways. Kaplan–Meier curves assessed the clinical relevance of core targets, and molecular docking evaluated the binding affinities between Tianjihuang components and key targets. Results Tianjihuang contained seven bioactive components targeting 207 genes, with 77 overlapping HCC-related targets. PPI analysis identified key targets, including AKT1, STAT3, EGFR, and ESR1, which play pivotal roles in HCC pathogenesis. GO and KEGG analysis revealed that Tianjihuang's anti-HCC effects involve multiple biological processes and pathways, such as cell proliferation, apoptosis, and PI3K-Akt signaling. Molecular docking results showed high binding affinities of key components, such as quercetin and gallic acid, with core targets supporting their potential therapeutic effects. Conclusion This study demonstrates that Tianjihuang exerts its anti-HCC effects through a multi-component, multi-target, and multi-pathway mechanism. These findings provide a scientific foundation for the clinical application of Tianjihuang and highlight its potential as a complementary therapy for HCC. |
| format | Article |
| id | doaj-art-49647fa03bbc48eabfd75d53c55b5363 |
| institution | OA Journals |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-49647fa03bbc48eabfd75d53c55b53632025-08-20T02:05:41ZengSpringerDiscover Oncology2730-60112025-06-0116111610.1007/s12672-025-02633-wUnveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking studyBixing Liang0Wenyu Wu1Fan He2Bing Yang3Dongxin Tang4Guizhou University of Traditional Chinese MedicineThe First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine oncology departmentThe First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine oncology departmentThe First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine oncology departmentThe First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine oncology departmentAbstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival. Hypericum japonicum Thunb. (Tianjihuang), a traditional Chinese medicine exhibits promising anticancer properties. This study aims to elucidate the multi-target mechanisms of Tianjihuang in treating HCC using network pharmacology and molecular docking techniques. Methods The active components of Tianjihuang and their targets were retrieved from TCMSP, PubChem, and Swiss Target Prediction databases. HCC-related targets were identified using GeneCard, OMIM, and TTD databases, and overlapping targets were analyzed. Protein–protein interaction (PPI) networks were constructed and analyzed using Cytoscape. Functional enrichment analysis of key targets was performed via GO and KEGG pathways. Kaplan–Meier curves assessed the clinical relevance of core targets, and molecular docking evaluated the binding affinities between Tianjihuang components and key targets. Results Tianjihuang contained seven bioactive components targeting 207 genes, with 77 overlapping HCC-related targets. PPI analysis identified key targets, including AKT1, STAT3, EGFR, and ESR1, which play pivotal roles in HCC pathogenesis. GO and KEGG analysis revealed that Tianjihuang's anti-HCC effects involve multiple biological processes and pathways, such as cell proliferation, apoptosis, and PI3K-Akt signaling. Molecular docking results showed high binding affinities of key components, such as quercetin and gallic acid, with core targets supporting their potential therapeutic effects. Conclusion This study demonstrates that Tianjihuang exerts its anti-HCC effects through a multi-component, multi-target, and multi-pathway mechanism. These findings provide a scientific foundation for the clinical application of Tianjihuang and highlight its potential as a complementary therapy for HCC.https://doi.org/10.1007/s12672-025-02633-wHepatocellular carcinomaTianjihuangNetwork pharmacologyMolecular dockingMulti-target therapy |
| spellingShingle | Bixing Liang Wenyu Wu Fan He Bing Yang Dongxin Tang Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study Discover Oncology Hepatocellular carcinoma Tianjihuang Network pharmacology Molecular docking Multi-target therapy |
| title | Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study |
| title_full | Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study |
| title_fullStr | Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study |
| title_full_unstemmed | Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study |
| title_short | Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study |
| title_sort | unveiling the mechanisms of tianjihuang in hepatocellular carcinoma a network pharmacology and molecular docking study |
| topic | Hepatocellular carcinoma Tianjihuang Network pharmacology Molecular docking Multi-target therapy |
| url | https://doi.org/10.1007/s12672-025-02633-w |
| work_keys_str_mv | AT bixingliang unveilingthemechanismsoftianjihuanginhepatocellularcarcinomaanetworkpharmacologyandmoleculardockingstudy AT wenyuwu unveilingthemechanismsoftianjihuanginhepatocellularcarcinomaanetworkpharmacologyandmoleculardockingstudy AT fanhe unveilingthemechanismsoftianjihuanginhepatocellularcarcinomaanetworkpharmacologyandmoleculardockingstudy AT bingyang unveilingthemechanismsoftianjihuanginhepatocellularcarcinomaanetworkpharmacologyandmoleculardockingstudy AT dongxintang unveilingthemechanismsoftianjihuanginhepatocellularcarcinomaanetworkpharmacologyandmoleculardockingstudy |